Racial disparities and cardiovascular disease: One size fits all approach?

Santoshi A Karnati1, Alexandra Wee1, Manasi M Shirke1

  • 1Department of Medicine, Queen's University Belfast School of Medicine, Belfast, UK.

Journal of Cardiac Surgery
|September 19, 2020
PubMed

Insights

Racial disparities in cardiovascular disease care persist despite advances. Addressing socioeconomic and cultural factors is key to improving health outcomes for minority populations and eliminating inequities.

Area of Science:

  • Cardiovascular Medicine
  • Health Equity Research
  • Public Health

Background:

  • Cardiovascular diseases remain a leading cause of death globally.
  • Significant healthcare inequities and disparities exist in cardiovascular disease (CVD) treatment and management.
  • These disparities disproportionately affect minority populations.

Purpose of the Study:

  • To investigate the impact of racial disparities on the treatment of various cardiovascular diseases.
  • To examine the influence of socioeconomic and cultural factors on these disparities.
  • To propose strategies for the elimination of healthcare inequities in CVD.

Main Methods:

  • A comprehensive literature review was performed.
  • Searches were conducted across major scientific databases including SCOPUS, Wiley, PubMed, and SAGE Journals.
  • Keywords focused on racial disparities, cardiovascular diseases, socioeconomic factors, and cultural influences.

Main Results:

  • Evidence confirms the existence of racial disparities in cardiovascular disease care.
  • Socioeconomic status and cultural beliefs significantly contribute to treatment inequities.
  • Minority populations experience poorer health outcomes due to these disparities.

Conclusions:

  • Continued research into healthcare inequalities is crucial.
  • Eliminating disparities has the potential to significantly improve health outcomes for minority populations.
  • Addressing socioeconomic and cultural determinants is vital for achieving health equity in cardiovascular care.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
720
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
647
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
507
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
225
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.1K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.8K